{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Fullerton",
      "address_1": "1941 W Commonwealth Ave",
      "reason_for_recall": "Marketed Without an Approved NDA/ANDA: All lots of the dietary supplement Slimdia Revolution are being recalled because they contain sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.",
      "address_2": "Suite B",
      "product_quantity": "unknown",
      "code_info": "There are no manufacturing codes associated with the product.",
      "center_classification_date": "20130215",
      "distribution_pattern": "Korea",
      "state": "CA",
      "product_description": "SLIMDIA Revolution capsules, 30-count capsules per bottle, Yerba Naturals, 19685 Varda Ave., Buena Park, CA.",
      "report_date": "20130227",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "P & J Trading Co",
      "recall_number": "D-165-2013",
      "initial_firm_notification": "Press Release",
      "product_type": "Drugs",
      "event_id": "63942",
      "termination_date": "20130325",
      "recall_initiation_date": "20121219",
      "postal_code": "92833-3042",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}